Morning Headlines 6/26/25
$40 Million to Obliterate Specialty Drug Paperwork
Mandolin, which uses AI agents to manage specialty drug intake, benefits, prior authorizations, and RCM, raises $40 million in seed and Series A funding.
Best Buy Sells Current Health Back To Co-Founder, Former CEO
Best Buy divests care-at-home technology company Current Health less than four years after acquiring it for $400 million, selling it back to co-founder and former CEO Christopher McGhee.
Health IT vendor BlueBriX announces $15 million in new funding.
Veradigm Provides 2025 Financial & Business Update
Veradigm expects to bring its SEC filings up to date sometime next year, after which it will seek to relist its stock.
"A valid concern..." Oh please. Everyone picks the software they like and the origin of that software is an afterthought.…